A γ-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains

Patricia Spilman, Pierre Lessard, Mamta Sattavat, Clarissa Bush, Thomas Tousseyn, Eric J. Huang, Kurt Giles, Todd Golde, Pritam Das, Abdul Fauq, Stanley B. Prusiner, Stephen J. DeArmond

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

In prion-infected mice, both the Notch-1 intracellular domain transcription factor (NICD) and the disease-causing prion protein (PrPSc) increase in the brain preceding dendritic atrophy and loss. Because the drug LY411575 inhibits the γ-secretase-catalyzed cleavage of Notch-1 that produces NICD, we asked whether this γ-secretase inhibitor (GSI) might prevent dendritic degeneration in mice with scrapie. At 50 d postinoculation with Rocky Mountain Laboratory (RML) prions, mice were given GSI orally for 43-60 d. Because we did not expect GSI to produce a reduction of PrPSc levels in brain, we added quinacrine (Qa) to the treatment regimen. Qa inhibits PrPSc formation in cultured cells. The combination of GSI and Qa reduced PrP Sc by ≈95% in the neocortex and hippocampus but only ≈50% in the thalamus at the site of prion inoculation. The GSI plus Qa combination prevented dendritic atrophy and loss, but GSI alone did not. Even though GSI reduced NICD levels to a greater extent than GSI plus Qa, it was unable to prevent dendritic degeneration. Whether a balance between NICD and dendrite growth-stimulating factors was achieved with GSI plus Qa but not GSI alone remains to be determined. Although the combination of GSI and Qa diminished PrPSc in the brains of RML-infected mice, GSI toxicity prevented us from being able to assess the effect the GSI plus Qa combination on incubation times. Whether less toxic GSIs can be used in place of LY411575 to prolong survival remains to be determined.

Original languageEnglish (US)
Pages (from-to)10595-10600
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume105
Issue number30
DOIs
StatePublished - Jul 29 2008

Fingerprint

Quinacrine
Amyloid Precursor Protein Secretases
Prions
Brain
N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide
Transcription Factors
Atrophy
Scrapie
Prion Diseases
Poisons
Neocortex
Dendrites
Thalamus
Cultured Cells
Hippocampus
Intercellular Signaling Peptides and Proteins

Keywords

  • Creutzfeldt-Jakob disease
  • Neuropathology
  • Prion disease
  • Scrapie
  • Therapy

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

A γ-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains. / Spilman, Patricia; Lessard, Pierre; Sattavat, Mamta; Bush, Clarissa; Tousseyn, Thomas; Huang, Eric J.; Giles, Kurt; Golde, Todd; Das, Pritam; Fauq, Abdul; Prusiner, Stanley B.; DeArmond, Stephen J.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 30, 29.07.2008, p. 10595-10600.

Research output: Contribution to journalArticle

Spilman, P, Lessard, P, Sattavat, M, Bush, C, Tousseyn, T, Huang, EJ, Giles, K, Golde, T, Das, P, Fauq, A, Prusiner, SB & DeArmond, SJ 2008, 'A γ-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains', Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10595-10600. https://doi.org/10.1073/pnas.0803671105
Spilman, Patricia ; Lessard, Pierre ; Sattavat, Mamta ; Bush, Clarissa ; Tousseyn, Thomas ; Huang, Eric J. ; Giles, Kurt ; Golde, Todd ; Das, Pritam ; Fauq, Abdul ; Prusiner, Stanley B. ; DeArmond, Stephen J. / A γ-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains. In: Proceedings of the National Academy of Sciences of the United States of America. 2008 ; Vol. 105, No. 30. pp. 10595-10600.
@article{5de7702aaed84365891fa2fd08012143,
title = "A γ-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains",
abstract = "In prion-infected mice, both the Notch-1 intracellular domain transcription factor (NICD) and the disease-causing prion protein (PrPSc) increase in the brain preceding dendritic atrophy and loss. Because the drug LY411575 inhibits the γ-secretase-catalyzed cleavage of Notch-1 that produces NICD, we asked whether this γ-secretase inhibitor (GSI) might prevent dendritic degeneration in mice with scrapie. At 50 d postinoculation with Rocky Mountain Laboratory (RML) prions, mice were given GSI orally for 43-60 d. Because we did not expect GSI to produce a reduction of PrPSc levels in brain, we added quinacrine (Qa) to the treatment regimen. Qa inhibits PrPSc formation in cultured cells. The combination of GSI and Qa reduced PrP Sc by ≈95{\%} in the neocortex and hippocampus but only ≈50{\%} in the thalamus at the site of prion inoculation. The GSI plus Qa combination prevented dendritic atrophy and loss, but GSI alone did not. Even though GSI reduced NICD levels to a greater extent than GSI plus Qa, it was unable to prevent dendritic degeneration. Whether a balance between NICD and dendrite growth-stimulating factors was achieved with GSI plus Qa but not GSI alone remains to be determined. Although the combination of GSI and Qa diminished PrPSc in the brains of RML-infected mice, GSI toxicity prevented us from being able to assess the effect the GSI plus Qa combination on incubation times. Whether less toxic GSIs can be used in place of LY411575 to prolong survival remains to be determined.",
keywords = "Creutzfeldt-Jakob disease, Neuropathology, Prion disease, Scrapie, Therapy",
author = "Patricia Spilman and Pierre Lessard and Mamta Sattavat and Clarissa Bush and Thomas Tousseyn and Huang, {Eric J.} and Kurt Giles and Todd Golde and Pritam Das and Abdul Fauq and Prusiner, {Stanley B.} and DeArmond, {Stephen J.}",
year = "2008",
month = "7",
day = "29",
doi = "10.1073/pnas.0803671105",
language = "English (US)",
volume = "105",
pages = "10595--10600",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "30",

}

TY - JOUR

T1 - A γ-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains

AU - Spilman, Patricia

AU - Lessard, Pierre

AU - Sattavat, Mamta

AU - Bush, Clarissa

AU - Tousseyn, Thomas

AU - Huang, Eric J.

AU - Giles, Kurt

AU - Golde, Todd

AU - Das, Pritam

AU - Fauq, Abdul

AU - Prusiner, Stanley B.

AU - DeArmond, Stephen J.

PY - 2008/7/29

Y1 - 2008/7/29

N2 - In prion-infected mice, both the Notch-1 intracellular domain transcription factor (NICD) and the disease-causing prion protein (PrPSc) increase in the brain preceding dendritic atrophy and loss. Because the drug LY411575 inhibits the γ-secretase-catalyzed cleavage of Notch-1 that produces NICD, we asked whether this γ-secretase inhibitor (GSI) might prevent dendritic degeneration in mice with scrapie. At 50 d postinoculation with Rocky Mountain Laboratory (RML) prions, mice were given GSI orally for 43-60 d. Because we did not expect GSI to produce a reduction of PrPSc levels in brain, we added quinacrine (Qa) to the treatment regimen. Qa inhibits PrPSc formation in cultured cells. The combination of GSI and Qa reduced PrP Sc by ≈95% in the neocortex and hippocampus but only ≈50% in the thalamus at the site of prion inoculation. The GSI plus Qa combination prevented dendritic atrophy and loss, but GSI alone did not. Even though GSI reduced NICD levels to a greater extent than GSI plus Qa, it was unable to prevent dendritic degeneration. Whether a balance between NICD and dendrite growth-stimulating factors was achieved with GSI plus Qa but not GSI alone remains to be determined. Although the combination of GSI and Qa diminished PrPSc in the brains of RML-infected mice, GSI toxicity prevented us from being able to assess the effect the GSI plus Qa combination on incubation times. Whether less toxic GSIs can be used in place of LY411575 to prolong survival remains to be determined.

AB - In prion-infected mice, both the Notch-1 intracellular domain transcription factor (NICD) and the disease-causing prion protein (PrPSc) increase in the brain preceding dendritic atrophy and loss. Because the drug LY411575 inhibits the γ-secretase-catalyzed cleavage of Notch-1 that produces NICD, we asked whether this γ-secretase inhibitor (GSI) might prevent dendritic degeneration in mice with scrapie. At 50 d postinoculation with Rocky Mountain Laboratory (RML) prions, mice were given GSI orally for 43-60 d. Because we did not expect GSI to produce a reduction of PrPSc levels in brain, we added quinacrine (Qa) to the treatment regimen. Qa inhibits PrPSc formation in cultured cells. The combination of GSI and Qa reduced PrP Sc by ≈95% in the neocortex and hippocampus but only ≈50% in the thalamus at the site of prion inoculation. The GSI plus Qa combination prevented dendritic atrophy and loss, but GSI alone did not. Even though GSI reduced NICD levels to a greater extent than GSI plus Qa, it was unable to prevent dendritic degeneration. Whether a balance between NICD and dendrite growth-stimulating factors was achieved with GSI plus Qa but not GSI alone remains to be determined. Although the combination of GSI and Qa diminished PrPSc in the brains of RML-infected mice, GSI toxicity prevented us from being able to assess the effect the GSI plus Qa combination on incubation times. Whether less toxic GSIs can be used in place of LY411575 to prolong survival remains to be determined.

KW - Creutzfeldt-Jakob disease

KW - Neuropathology

KW - Prion disease

KW - Scrapie

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=48749106225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48749106225&partnerID=8YFLogxK

U2 - 10.1073/pnas.0803671105

DO - 10.1073/pnas.0803671105

M3 - Article

C2 - 18647832

AN - SCOPUS:48749106225

VL - 105

SP - 10595

EP - 10600

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 30

ER -